keyword
https://read.qxmd.com/read/38620053/tagraxofusp-a-first-in-class-cd123-targeted-agent-five-year-postapproval-comprehensive-review-of-the-literature
#1
REVIEW
Wei-Ying Jen, Marina Konopleva, Naveen Pemmaraju
Tagraxofusp is a first-in-class CD123-directed conjugate of an amended diphtheria toxin platform and recombinant interleukin 3. Binding and subsequent internalization of the drug result in cell death via disruption of intracellular protein synthesis. CD123 is a surface marker that is expressed in several hematological malignancies, especially blastic plasmacytoid dendritic cell neoplasm (BPDCN), where its expression is ubiquitous. A pivotal study of tagraxofusp in BPDCN resulted in its approval for the treatment of BPDCN, the first treatment approved for this indication...
April 15, 2024: Cancer
https://read.qxmd.com/read/38619917/adverse-childhood-experiences-individual-level-risk-and-protective-factors-and-recent-drug-use-in-a-community-sample-of-nigerian-women
#2
JOURNAL ARTICLE
Martin Osayande Agwogie, Wendy Kliewer, Muhammed Bashir Ibrahim
Adverse childhood experiences (ACEs) are associated with a wide range of health problems and health-compromising behaviors, including drug use, but are understudied in sub-Saharan Africa. Further, some data suggest that some types of ACEs are more strongly associated with outcomes than others. We investigated associations between different types of ACEs and recent drug use among 2,011 women living in Katsina State, Nigeria. This community-based survey included questions on ACE exposure, modifiable individual-level risk and promotive factors, and past-year drug use...
April 15, 2024: Journal of Traumatic Stress
https://read.qxmd.com/read/38619719/real-world-effectiveness-and-safety-of-ramucirumab-as-a-second-line-treatment-for-patients-with-unresectable-advanced-or-metastatic-gastric-gastroesophageal-junction-adenocarcinoma-in-japan-and-south-korea-a-systematic-literature-review
#3
REVIEW
Xiaotian Zhang, Li Zhou, Chan Zhou, Lin Shen
INTRODUCTION: Gastric cancer has the highest incidence and mortality in Eastern Asia. The efficacy and safety of ramucirumab (RAM) monotherapy or in combination with paclitaxel (PTX) for patients with unresectable advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (G/GEA) have been established in clinical trials. To assess the effectiveness and safety of RAM or RAM-based therapy as a second-line treatment in real-world clinical practice in Eastern Asia and to pave the way for future research, a systematic literature review (SLR) was conducted...
April 15, 2024: Advances in Therapy
https://read.qxmd.com/read/38619581/a-case-of-rapid-avacopan-induced-liver-injury-in-pediatric-granulomatosis-with-polyangiitis
#4
JOURNAL ARTICLE
Tomohiko Nishino, Shinya Tomori, Mei Haruyama, Kazuhiro Takahashi, Masakazu Mimaki
Children with anti-neutrophil cytoplasmic antibody-associated vasculitis benefit immensely from avacopan as it reduces the requirement for steroids. However, descriptions of adverse drug reactions in children are lacking, and the dosage and follow-up intervals are unclear. A 10-year-old boy with initial granulomatosis and polyangiitis presented with diffuse pulmonary hemorrhage. Rituximab and 30 mg avacopan were administered twice daily as induction therapy following methylprednisolone pulse therapy. However, sudden liver function test abnormalities were observed on day 31 of avacopan treatment, despite liver enzyme levels being within the normal range 5 days earlier...
April 15, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38619380/safety-and-effectiveness-of-certolizumab-pegol-in-japanese-patients-with-rheumatoid-arthritis-up-to-3-year-results-from-a-postmarketing-surveillance-study
#5
JOURNAL ARTICLE
Hideto Kameda, Keiichiro Nishida, Toshihiro Nanki, Akira Watanabe, Yukiya Oshima, Shigeki Momohara
OBJECTIVES: To report up to 3-year safety and effectiveness of certolizumab pegol (CZP) in Japanese patients with rheumatoid arthritis from a postmarketing surveillance study. METHODS: Patients enrolled previously completed 24 weeks of CZP in the 24-week postmarketing surveillance study. Adverse drug reactions (ADRs) were recorded for patients who received ≥1 CZP dose. Effectiveness outcomes were 28-joint Disease Activity Score with erythrocyte sedimentation rate and European Alliance of Associations for Rheumatology response...
March 29, 2024: Modern Rheumatology
https://read.qxmd.com/read/38619365/reversible-assembly-of-proteins-and-phenolic-polymers-for-intracellular-protein-delivery-with-serum-stability
#6
JOURNAL ARTICLE
Guangyu Rong, Xujiao Zhou, Jiaxu Hong, Yiyun Cheng
The design of intracellular delivery systems for protein drugs remains a challenge due to limited delivery efficacy and serum stability. Herein, we propose a reversible assembly strategy to assemble cargo proteins and phenolic polymers into stable nanoparticles for this purpose using a heterobifunctional adaptor (2-formylbenzeneboronic acid). The adaptor is easily decorated on cargo proteins via iminoboronate chemistry and further conjugates with catechol-bearing polymers to form nanoparticles via boronate diester linkages...
April 15, 2024: Nano Letters
https://read.qxmd.com/read/38619193/association-between-cdk4-6-inhibitors-and-drug-related-osteonecrosis-of-the-jaw-a-pharmacoepidemiological-study-using-the-fda-adverse-events-reporting-system
#7
JOURNAL ARTICLE
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
The most common toxicities associated with cyclin-dependent kinase (CDK) 4/6 inhibitor therapy include decreased leukopenia and neutropenia due to the inhibition of CDK6 of leukocyte and neutrophil precursors in bone marrow. These hematological toxicities are more commonly observed with palbociclib administration than with abemaciclib administration, which is approximately 13 times more selective against CDK4 than CDK6. Thus, even though both successfully inhibit CDK4/6, the side effects of palbociclib and abemaciclib differ due to differences in selectivity...
April 15, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38619027/exploring-the-impact-of-co-exposure-timing-on-drug-drug-interactions-in-signal-detection-through-spontaneous-reporting-system-databases-a-scoping-review
#8
REVIEW
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
INTRODUCTION: Drug-drug interactions (DDIs) are defined as the pharmacological effects produced by the concomitant administration of two or more drugs. To minimize false positive signals and ensure their validity when analyzing Spontaneous Reporting System (SRS) databases, it has been suggested to incorporate key pharmacological principles, such as temporal plausibility. AREAS COVERED: the scoping review of the literature was completed using MEDLINE from inception to March 2023...
April 15, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38618912/doxycycline-induced-gastric-injury
#9
JOURNAL ARTICLE
H H W Liu, T W Ho, N S K Tsang, J T W Lam, Y T Hui
No abstract text is available yet for this article.
April 15, 2024: Hong Kong Medical Journal
https://read.qxmd.com/read/38618759/supramolecular-salicylic-acid-combined-with-niacinamide-in-chloasma-a-randomized-controlled-trial
#10
JOURNAL ARTICLE
Ying Xiong, Xian Jiang, Wei Lai, Xinghua Gao, Yan You, Yongmei Huang, Xueli Li, Junling Zhang, Shiqin Tao, Jin Chen, Wei Zhang, Nan Yu, Nan Xu, Chunling Liu, Weihui Zeng, Shichao Lv, Gang Wang
BACKGROUND: No trial of supramolecular salicylic acid (SSA) for chloasma is available yet. OBJECTIVE: The purpose of this study was to assess the efficacy and safety of Bole DA 30% supramolecular salicylic acid (SSA) combined with 10% niacinamide in treating chloasma. METHODS: This multicenter (n=15), randomized, double-blind, parallel placebo-controlled trial randomized the subjects (1:1) to Bole DA 30% SSA or placebo. The primary endpoint was the effective rate after 16 weeks using the modified melasma area severity index (mMASI) [(pretreatment-posttreatment)/pretreatment×100%]...
April 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38618373/metronidazole-induced-acute-cerebellitis-in-a-young-patient-unusual-onset-delayed-remission-and-characteristic-imaging-features
#11
Venkat Reddy, Sunil Kumar, Sourya Acharya, Jasleen Kakkad, Mamtha Jadhav
Metronidazole-induced acute cerebellitis is an exceptionally rare condition resulting from severe adverse reactions to metronidazole, a medication generally employed in the management of infections caused by anaerobic microbes. Although neuropathy has been linked to metronidazole use, reports of acute cerebellitis are infrequent. The neurological effects associated with metronidazole can include weakness, dysarthria, postural instability, seizures, giddiness, vertigo, ataxia, confusion, encephalopathy, headaches, and tremors...
March 2024: Curēus
https://read.qxmd.com/read/38618296/efficacy-of-electroacupuncture-combined-with-chinese-herbal-medicine-on-pain-intensity-for-chronic-sciatica-secondary-to-lumbar-disc-herniation-study-protocol-for-a-randomised-controlled-trial
#12
JOURNAL ARTICLE
Jing-Chun Xia, Yu-Cheng Huang, Ke Wu, Jian Pang, Ying Shi
PURPOSE: Chinese herbal medicine and electroacupuncture (EA) have been used to control pain for many decades in China. We aim to explore the efficacy of intervening patients whose discogenic sciatica symptoms lasting longer than 3 months with these conservative treatments. PATIENTS AND METHODS: This is a single-center, parallel-group, patient-unblinded Randomized Controlled Trial (RCT) with blinded outcome assessment and statistician. One hundred and twenty-four patients will be assigned randomly into 2 groups including conservative treatment group (Shenxie Zhitong capsule combined with EA treatment) and Nonsteroidal Anti-inflammatory Drugs (Nonsteroidal Anti-inflammatory Drugs, NSAIDs) control group (Celecoxib) in a 1:1 ratio...
2024: Journal of Pain Research
https://read.qxmd.com/read/38618248/antibody-platinum-iv-prodrugs-conjugates-for-targeted-treatment-of-cutaneous-squamous-cell-carcinoma
#13
JOURNAL ARTICLE
Xiangye Yin, Yingjie Zhuang, Haiqin Song, Yujian Xu, Fan Zhang, Jianxin Cui, Lei Zhao, Yingjie Yu, Qixu Zhang, Jun Ye, Youbai Chen, Yan Han
Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a typical antibody that offers the benefits of good targeting and safety for individuals with advanced and inoperable cutaneous squamous cell carcinoma (cSCC); however, its anti-tumor activity is limited to a single use...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38618202/efficacy-and-safety-of-gst-hg171-in-adult-patients-with-mild-to-moderate-covid-19-a-randomised-double-blind-placebo-controlled-phase-2-3-trial
#14
JOURNAL ARTICLE
Hongzhou Lu, George Zhang, John Mao, Xiaochun Chen, Yangqing Zhan, Ling Lin, Tianxiang Zhang, Yanan Tang, Feng Lin, Feiyue Zhu, Yuanlong Lin, Yiming Zeng, Kaiyu Zhang, Wenfang Yuan, Zhenyu Liang, Ruilin Sun, Liya Huo, Peng Hu, Yihua Lin, Xibin Zhuang, Zhaohui Wei, Xia Chen, Wenhao Yan, Xiuping Yan, Lisa Mu, Zhuhua Lin, Xinyu Tu, Hongshan Tan, Fuhu Huang, Zhiqiang Hu, Hongming Li, Guoping Li, Haijun Fu, Zifeng Yang, Xinwen Chen, Fu-Sheng Wang, Nanshan Zhong
BACKGROUND: GST-HG171 is a potent, broad-spectrum, orally bioavailable small-molecule 3C like protease inhibitor that has demonstrated greater potency and efficacy compared to Nirmatrelvir in pre-clinical studies. We aimed to evaluate the efficacy and safety of orally administered GST-HG171 plus Ritonavir in patients with coronavirus disease 2019 (COVID-19) infected with emerging XBB and non-XBB variants. METHODS: This randomised, double-blind, placebo-controlled phase 2/3 trial was conducted in 47 sites in China among adult patients with mild-to-moderate COVID-19 with symptoms onset ≤72 h...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38618137/maximum-tolerated-dose-and-toxicity-evaluation-of-orally-administered-docetaxel-granule-in-mice
#15
JOURNAL ARTICLE
Xiaowei Dong, Jinmin Zhang
Oral delivery of chemotherapy drugs is the most favorable and preferred route of drug administration. However, because of poor solubility and/or permeability, most chemotherapy drugs are given by intravenous administration. Docetaxel (DTX) is a potent chemotherapy drug that inhibits microtubular depolymerization and is widely used to treat numerous cancers. DTX is highly lipophilic and insoluble in water; thus, 50% polysorbate 80, which may cause hypersensitivity reactions and reduce drug uptake by tumor tissue, is used in the commercial DTX injection to dissolve DTX...
June 2024: Toxicology Reports
https://read.qxmd.com/read/38618136/the-addition-of-mammalian-cell-culture-medium-impacts-nanoparticle-toxicity-in-zebrafish
#16
JOURNAL ARTICLE
John V Lam, Ryan L Lopez, Lisa Truong, Robyn L Tanguay
Engineered nanomaterials (ENMs) are ubiquitous in contemporary applications, yet their environmental and human health impacts remain inadequately understood. This study addresses the challenge of identifying potential risks associated with ENM exposure by highlighting the significant variability in existing research methodologies. Without a systematic collection of toxicological data that encompasses standardized materials, relevant platforms, and assays, the task of identifying potential risks linked to ENM exposure becomes an intricate challenge...
June 2024: Toxicology Reports
https://read.qxmd.com/read/38617895/analysis-of-a-serious-adverse-reaction-of-pulmonary-fibrosis-caused-by-dronedarone
#17
Yuyan Chen, Zhendong Fu, Xue Wen, Mingxia Zhang, Qiong Min, Peng Wang, Jin Zhang, Jun Ren, Wenbin Li, Rong Wang
OBJECTIVE: This study aims to analyze a severe adverse reaction of pulmonary fibrosis induced by dronedarone hydrochloride tablets, and to provide a reference for clinical rational medication through drug precautions. METHODS: A case of pulmonary fibrosis induced by dronedarone hydrochloride tablets, along with related literature was retrospectively analyzed. RESULTS: Patients over 65 years old with a history of exposure to amiodarone may increase the incidence of pulmonary toxicity induced by dronedarone, and dronedarone should not be selected as a substitute treatment drug for patients with amiodarone-induced pulmonary toxicity...
2024: Current Therapeutic Research, Clinical and Experimental
https://read.qxmd.com/read/38617837/concomitant-bedaquiline-and-delamanid-therapy-in-patients-with-drug-resistant-extra-pulmonary-tuberculosis-in-mumbai-india
#18
JOURNAL ARTICLE
Himani Mongia, Fatima Mamnoon, Arunima Silsarma, Raman Mahajan, Alpa Dalal, Miriam Arago Galindo, Aparna Iyer, Pramila Singh, Homa Mansoor, Mrinalini Das, Mabel Morales, Hannah Spencer, Petros Isaakidis
BACKGROUND: World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised regimens for eligible patients with pulmonary drug-resistant tuberculosis (DR-TB); however, data for patients with drug-resistant extrapulmonary tuberculosis (EPTB) is extremely limited. This study documents the treatment outcomes and adverse events associated with concurrent BDQ-DLM-based regimens in patients with drug-resistant EPTB at a Médecins Sans Frontières clinic in Mumbai, India...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38617792/understanding-the-action-mechanisms-of-metformin-in-the-gastrointestinal-tract
#19
REVIEW
Meihui Cheng, Lili Ren, Xianxian Jia, Jianwei Wang, Bin Cong
Metformin is the initial medication recommended for the treatment of type 2 diabetes mellitus (T2DM). In addition to diabetes treatment, the function of metformin also can be anti-aging, antiviral, and anti-inflammatory. Nevertheless, further exploration is required to fully understand its mode of operation. Historically, the liver has been acknowledged as the main location where metformin reduces glucose levels, however, there is increasing evidence suggesting that the gastrointestinal tract also plays a significant role in its action...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38617769/clinical-use-of-macitentan-in-the-treatment-of-connective-tissue-disease-associated-pulmonary-arterial-hypertension
#20
JOURNAL ARTICLE
Xiaohui Song, Xiangrui Sheng, Lei Ding, Jian Wu, Xin Chang, Erye Zhou, Jing Cao, Tao Cheng, Mingjun Wang
BACKGROUND: Connective tissue disease (CTD) is the second most common cause of the pulmonary arterial hypertension (PAH). Currently, clinical data concerning CTD-PAH is scarce. Our study aimed to assess the efficacy and safety of macitentan in the treatment of CTD-PAH. METHODS: In this retrospective study, patients diagnosed with CTD-PAH at The First Affiliated Hospital of Soochow University from April 2020 to November 2021 were included. Of the patients, 9 were switched to macitentan monotherapy whereas 23 received initial combination therapy...
March 29, 2024: Journal of Thoracic Disease
keyword
keyword
162531
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.